Cite
HARVARD Citation
Aliprantis, A. et al. (2021). A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Human vaccines & immunotherapeutics. 17 (5), pp. 1248-1261. [Online].